Cargando…
Impact of prostate focused alignment on planned pelvic lymph node dose
PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered u...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292696/ https://www.ncbi.nlm.nih.gov/pubmed/34231945 http://dx.doi.org/10.1002/acm2.13092 |
_version_ | 1783724876588122112 |
---|---|
author | Kilian‐Meneghin, Joshua Ma, Tianjun Kumaraswamy, Lalith |
author_facet | Kilian‐Meneghin, Joshua Ma, Tianjun Kumaraswamy, Lalith |
author_sort | Kilian‐Meneghin, Joshua |
collection | PubMed |
description | PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered using portal‐imaging. However, the pelvic lymph nodes are affixed to the bony anatomy and are not mobile in concert with the prostate. The aim of this study was to determine whether a significant difference in pelvic lymph node coverage exists between planned and delivered external beam therapy treatments for these patients. METHODS: The recorded prostate motions were gathered for 19 patients; conjointly the pelvic lymph node motions were determined by manual registration of the bony anatomy in the kV‐images. The difference between the prostate and the bony anatomy coordinates was input into Eclipse as field shifts to represent the deviation in planned vs delivered pelvic lymph node coverage. RESULTS: Structure volume at V(100) was recorded for each patient for two structures: summed pelvic lymph nodes (LN CTV) and pelvic lymph nodes +1 cm margin (LN PTV) to express their contribution to the PTV. For the LN PTV, the average difference between the planned coverage and calculated delivered coverage was 3.5%, with a paired t‐test value of P = 0.005. Based upon bony anatomy registration, 26% of patients received less than 95% dose coverage using V(100) criteria for LN PTV. Dose value differences between the two plans at minimum were 6.96 ± 6.23 Gy, at mean were 0.54 ± 0.40 Gy, and at maximum were 0.10 ± 0.29 Gy. For the LN CTV, the average difference between the planned coverage and calculated delivered coverage was 1%, with a paired t‐test value of P = 0.53. CONCLUSIONS: The results indicate a significant difference exists between the planned coverage and calculated delivered coverage for the LN PTV. There was no significant difference found for the LN CTV. We conclude that lymph node motion must be considered with the prostate motion when aligning patients before each fraction. |
format | Online Article Text |
id | pubmed-8292696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82926962021-07-22 Impact of prostate focused alignment on planned pelvic lymph node dose Kilian‐Meneghin, Joshua Ma, Tianjun Kumaraswamy, Lalith J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered using portal‐imaging. However, the pelvic lymph nodes are affixed to the bony anatomy and are not mobile in concert with the prostate. The aim of this study was to determine whether a significant difference in pelvic lymph node coverage exists between planned and delivered external beam therapy treatments for these patients. METHODS: The recorded prostate motions were gathered for 19 patients; conjointly the pelvic lymph node motions were determined by manual registration of the bony anatomy in the kV‐images. The difference between the prostate and the bony anatomy coordinates was input into Eclipse as field shifts to represent the deviation in planned vs delivered pelvic lymph node coverage. RESULTS: Structure volume at V(100) was recorded for each patient for two structures: summed pelvic lymph nodes (LN CTV) and pelvic lymph nodes +1 cm margin (LN PTV) to express their contribution to the PTV. For the LN PTV, the average difference between the planned coverage and calculated delivered coverage was 3.5%, with a paired t‐test value of P = 0.005. Based upon bony anatomy registration, 26% of patients received less than 95% dose coverage using V(100) criteria for LN PTV. Dose value differences between the two plans at minimum were 6.96 ± 6.23 Gy, at mean were 0.54 ± 0.40 Gy, and at maximum were 0.10 ± 0.29 Gy. For the LN CTV, the average difference between the planned coverage and calculated delivered coverage was 1%, with a paired t‐test value of P = 0.53. CONCLUSIONS: The results indicate a significant difference exists between the planned coverage and calculated delivered coverage for the LN PTV. There was no significant difference found for the LN CTV. We conclude that lymph node motion must be considered with the prostate motion when aligning patients before each fraction. John Wiley and Sons Inc. 2021-07-07 /pmc/articles/PMC8292696/ /pubmed/34231945 http://dx.doi.org/10.1002/acm2.13092 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Kilian‐Meneghin, Joshua Ma, Tianjun Kumaraswamy, Lalith Impact of prostate focused alignment on planned pelvic lymph node dose |
title | Impact of prostate focused alignment on planned pelvic lymph node dose |
title_full | Impact of prostate focused alignment on planned pelvic lymph node dose |
title_fullStr | Impact of prostate focused alignment on planned pelvic lymph node dose |
title_full_unstemmed | Impact of prostate focused alignment on planned pelvic lymph node dose |
title_short | Impact of prostate focused alignment on planned pelvic lymph node dose |
title_sort | impact of prostate focused alignment on planned pelvic lymph node dose |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292696/ https://www.ncbi.nlm.nih.gov/pubmed/34231945 http://dx.doi.org/10.1002/acm2.13092 |
work_keys_str_mv | AT kilianmeneghinjoshua impactofprostatefocusedalignmentonplannedpelviclymphnodedose AT matianjun impactofprostatefocusedalignmentonplannedpelviclymphnodedose AT kumaraswamylalith impactofprostatefocusedalignmentonplannedpelviclymphnodedose |